GeminIQ Website Logo

Viewing USPH free

Subscribe for full history, 90+ metrics, screener, watchlist...

U S PHYSICAL THERAPY INC /NV

USPH

Companies in Services-Health Services

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value
283631343941117113132153148161
Accounts Receivable Net Current
696468666559575555525354
Accounts And Other Receivables Net Current
282424272627202222181817
Other Assets Current
14161613151111121211910
Assets Current
139140138141145138205202221233228242
Property Plant And Equipm…
Furniture And Fixtures Gross
706868676968676666646563
Leasehold Improvements Gross
615958555451484947474645
Property Plant And Equipment Gross
132127126122122119115115113111111109
Accumulated Depreciation Depletion And Amortizatio…
-93-91-91-90-90-87-89-88-87-858584
Property Plant And Equipment Net
393634323332272626262625
Operating Lease Right Of Use Asset
149144140137133134104105102103103102
Investments In Affiliates Subsidiaries Associates …
121212121212121212121212
Goodwill
716692690678674667555549534510523507
Intangible Assets Net Excluding Goodwill
180173176176177179124124117110112108
Other Assets Noncurrent
775445354365
Assets
1,2421,2041,1961,1801,1801,1671,0291,0231,0179979971,000
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Trade Current
767466645454
Accrued Liabilities Current
578157656860655854553643
Operating Lease Liability Current
434242414040353535353431
Long Term Debt Current
11109891110109888
Liabilities Current
1171391151191241161151071031028286
Long Term Notes Payable
101001121122
Long Term Line Of Credit
753127252811---000
Long Term Loans Payable
119122124127129131132134136138139141
Deferred Income Tax Liabilities Net
312836343429252727252623
Operating Lease Liability Noncurrent
115111106104101102777876777779
Other Liabilities Noncurrent
235551886321513
Liabilities
459434414414421408358353345345342344
Redeemable Noncontrolling Interest Equity Carrying…
313293278263260269187184191175175166
Stockholders Equity
Preferred Stock Value
000000000000
Common Stock Value
000000000000
Additional Paid In Capital
288286297295293290287285284281279277
Accumulated Other Comprehensive Income Loss Net Of…
111123144365
Retained Earnings Accumulated Deficit
217227237236234227226226224224239238
Treasury Stock Value
-37-37-32-32-32-32-32-32-32-32-32-32
Stockholders Equity
469476505502497489484485481477492488
Minority Interest
001221111122
Liabilities And Stockholders Equity
1,2421,2041,1961,1801,1801,1671,0291,0231,0179971,0101,000
Allowance For Doubtful Accounts Receivable Current
444444333323
Stockholders Equity Inclu…
Preferred Stock Par Or Stated Value Per Share
0.010.010.010.010.010.010.010.010.010.010.010.01
Preferred Stock Shares Authorized
111111111111
Preferred Stock Shares Issued
000000000000
Preferred Stock Shares Outstanding
000000000000
Common Stock Par Or Stated Value Per Share
0.010.010.010.010.010.010.010.010.010.010.010.01
Common Stock Shares Authorized
202020202020202020202020
Common Stock Shares Issued
181717171717171717171717
Treasury Stock Common Shares
222222222222

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
20269.18%16.86%26.72%---------
20251.85%7.34%0.84%-4.96%-4.37%6.82%0.60%10.34%16.75%-10.44%-7.15%-23.84%
2024-0.89%-10.70%-4.99%4.13%-0.19%0.22%4.38%-3.95%-5.63%-9.15%-10.92%-6.11%
2023----7.64%-15.48%-22.15%6.54%13.10%14.33%4.57%-6.36%0.85%

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Performance and Valuation Metrics

Metrics
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
1.19
1.01
1.20
1.18
1.17
1.18
1.78
1.88
2.16
2.28
2.77
2.82
Quick Ratio
1.19
1.01
1.20
1.18
1.17
1.18
1.78
1.88
2.16
2.28
2.77
2.82
Working Capital
21.81M
950.00K
23.36M
21.69M
21.56M
21.30M
89.57M
94.58M
118.61M
131.19M
146.14M
155.98M
Leverage & Debt
Debt to Equity
0.98
0.91
0.82
0.82
0.85
0.83
0.74
0.73
0.72
0.72
0.70
0.70
Debt Ratio
0.37
0.36
0.35
0.35
0.36
0.35
0.35
0.35
0.34
0.35
0.34
0.34
Efficiency & Turnover
Asset Turnover TTM
0.66
0.66
0.68
0.66
0.64
0.62
0.64
0.62
0.65
0.65
0.66
0.65
Days Sales Outstanding TTM
30.71
28.81
29.98
30.17
31.34
30.15
31.08
31.68
33.40
31.32
31.71
32.94
Receivables Turnover TTM
11.89
12.67
12.17
12.10
11.65
12.11
11.74
11.52
10.93
11.65
11.51
11.08
Per Share Metrics
Diluted EPS TTM
2.49
2.61
3.87
3.44
3.14
3.03
1.84
2.02
2.25
2.62
1.80
1.99
Free Cash Flow Per Share TTM
4.40
4.02
3.74
4.01
3.70
4.36
4.87
4.49
4.39
5.12
4.30
4.49
Dividend Per Share TTM
2.09
2.04
2.03
2.01
2.00
1.97
1.96
1.94
1.82
1.93
1.76
1.84
Margin Metrics
Gross Profit Margin TTM
19.03%
19.17%
18.73%
18.41%
18.10%
18.46%
18.88%
19.23%
19.45%
20.09%
20.10%
20.26%
Operating Profit Margin TTM
10.00%
11.10%
11.80%
10.56%
9.68%
9.38%
6.58%
7.25%
8.17%
8.61%
10.10%
10.12%
Net Profit Margin TTM
4.76%
5.07%
7.76%
7.17%
6.78%
6.79%
4.31%
4.85%
5.53%
6.15%
4.56%
4.69%
Growth Metrics
Net Revenue Growth (1Y)
13.73%
16.33%
17.50%
16.24%
14.30%
11.00%
9.22%
8.07%
7.37%
9.34%
9.12%
9.98%
Net Income Growth (1Y)
-20.26%
-13.20%
111.69%
72.02%
40.23%
22.51%
3.10%
11.59%
7.08%
15.74%
-35.76%
-35.73%
EPS Growth (1Y)
-20.44%
-13.83%
109.92%
70.61%
39.17%
15.39%
2.49%
1.58%
-7.13%
5.93%
-44.27%
-39.11%
Valuation Metrics
P/E TTM
29.83
29.54
21.52
22.15
22.37
28.25
44.03
43.68
47.59
33.59
48.00
57.26
P/B TTM
2.40
2.45
2.51
2.31
2.13
2.63
2.53
2.74
3.35
2.62
2.63
3.20
P/S TTM
1.42
1.50
1.67
1.59
1.52
1.92
1.90
2.12
2.63
2.07
2.19
2.69
Market Cap
1.13B
1.17B
1.27B
1.16B
1.06B
1.29B
1.22B
1.33B
1.61B
1.25B
1.29B
1.56B
Enterprise Value
1.11B
1.14B
1.24B
1.13B
1.03B
1.26B
1.12B
1.23B
1.49B
1.11B
1.16B
1.41B
Calculated Values
Free Cash Flow TTM
66.68M
60.99M
56.90M
60.87M
55.92M
65.75M
73.45M
67.67M
65.98M
72.68M
64.41M
61.60M
Net Debt
-17.07M
-25.29M
-21.72M
-25.60M
-29.54M
-29.46M
-106.82M
-101.70M
-122.26M
-143.85M
-138.09M
-151.01M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2026-06-09Purchase
Owner: Minan, Peter Francis
Title: -
Shares: 288
Price/Share: $61.50
Value: $17,712.00
Shares Owned: 3,211
Relationship: Director
Ownership: Direct
2026-03-11Sale
Owner: Reeve, Graham D.
Title: COO
Shares: 662
Price/Share: $78.86
Value: $52,205.32
Shares Owned: 30,078
Relationship: Officer
Ownership: Direct
2026-03-09Sale
Owner: Reeve, Graham D.
Title: COO
Shares: 1
Price/Share: $78.52
Value: $78.52
Shares Owned: -
Relationship: Officer
Ownership: Indirect
2026-03-06Sale
Owner: Binstein, Richard
Title: EVP Gen'l Counsel & Secretary
Shares: 3,000
Price/Share: $81.64
Value: $244,920.00
Shares Owned: 24,867
Relationship: Officer
Ownership: Direct
2025-11-24Sale
Owner: Reeve, Graham D.
Title: COO
Shares: 743
Price/Share: $71.01
Value: $52,760.43
Shares Owned: 20,740
Relationship: Officer
Ownership: Direct

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2026-03-31
102.04%
Inst. Shares: 15,476,539
Shares Outstanding: 15,167,000
2025-12-31
102.34%
Inst. Shares: 15,530,027
Shares Outstanding: 15,175,000
2025-09-30
101.98%
Inst. Shares: 15,505,441
Shares Outstanding: 15,204,000
2025-06-30
96.03%
Inst. Shares: 14,593,400
Shares Outstanding: 15,197,000
2025-03-31
97.02%
Inst. Shares: 14,681,671
Shares Outstanding: 15,132,000

U S PHYSICAL THERAPY INC /NV (USPH) — SEC Financial Statements & Analysis

U S PHYSICAL THERAPY INC /NV (USPH) is a services-health services company, incorporated in NV. U S PHYSICAL THERAPY INC /NV trades on NYSE as: USPH. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), U S PHYSICAL THERAPY INC /NV reported a 13.73% year-over-year revenue growth, a Gross Profit Margin of 19.03% (TTM), a Debt-to-Equity ratio of 0.98x, a Price-to-Sales (P/S) ratio of 1.42x (TTM), a Price-to-Book (P/B) ratio of 2.4 (TTM), at a market cap of $1.13B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y
13.73%
Gross Profit Margin TTM
19.03%
Debt To Equity
0.98x
P/S TTM
1.42x
P/B TTM
2.4
Market Cap
$1.13B

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is U S PHYSICAL THERAPY INC /NV in?

U S PHYSICAL THERAPY INC /NV (USPH) operates in the Services-Health Services industry.

What is USPH's market cap?

U S PHYSICAL THERAPY INC /NV (USPH) has a market capitalization of $1.13B as of 2026-03-31.

What is USPH's P/E ratio?

U S PHYSICAL THERAPY INC /NV (USPH)'s trailing twelve month P/E ratio is 29.83x as of 2026-03-31.

What exchange does USPH trade on?

U S PHYSICAL THERAPY INC /NV (USPH) trades on the NYSE.

Where is U S PHYSICAL THERAPY INC /NV incorporated?

U S PHYSICAL THERAPY INC /NV is incorporated in NV.

Research Faster.
Invest Smarter.

U S PHYSICAL THERAPY INC /NV (USPH) financial data sourced directly from SEC EDGAR filings — including the latest 10-K annual report, 10-Q quarterly filings, insider transactions (SEC Form 4), institutional ownership (SEC Form 13F), Earning Marker Reaction Heat Map and 90+ calculated financial metrics like Price to Earnings Ratio (P/E), Return on Equity (ROE), Debt to Equity (D/E), Free Cash Flow Per Share (FCF/S), and Return on Invested Capital (ROIC). Unlike platforms that rely on third-party data aggregators, GeminIQ parses raw SEC filings directly — delivering institutional-grade accuracy at a fraction of the cost of Bloomberg Terminal or S&P Capital IQ.